Tag Archives: Oncology

ITALY – Pisa. Hematopoietic stem cell collection center opens

The Pisa University Hospital has become part of the international network of hematopoietic stem cell transplant facilities (meaning they produce various blood components). The hospital was recently accredited by the Italian registry of bone marrow donors, which is part of the international network.

Pisa has become an important center for bone marrow collection for all potential donors in northwestern Italy.
On 20 April 2009, the first donation was carried out for a patient at the Udine University Hospital, and a second donation is being organized for a patient being treated at the Montpellier Hospital (France).

The hospital in Pisa received the
Read More…


December 4, 2009- Working with mice, scientists at Johns Hopkins publishing in the December issue of Neoplasia have shown that a protein made by a gene called “Twist” may be the proverbial red flag that can accurately distinguish stem cells that drive aggressive, metastatic breast cancer from other breast cancer cells.

Building on recent work suggesting that it is a relatively rare subgroup of stem cells in breast tumors that drives breast cancer, scientists have surmised that this subgroup of cells must have some very distinctive qualities and characteristics.

ITALY – Mesenchymal Stem Cell Transplants and Drugs Against Tumor Stem Cells

Image via Wikipedia

Oncologists are now faced with the challenge of understanding how specialized drugs can strike tumor stem cells and impair their ability to replicate and spread. This is one of the most important questions that researchers will have to answer in upcoming years according to Regina Elena Institute hematologist Michele Milella. In San Francisco at the American Society of Hematology (ASH) Congress Milella spoke about future hematology issues, including fighting blood borne tumors with stem cell transplants over the past years.

“The ASH in this sense is an excellent indicator for where research is going, and
Read More…

ITALY – Here’s Why Cancer Stem Cells Are Immortal

Image via Wikipedia

Scientists at the FIRC (Italian Foundation for Cancer Research) Institute of Molecular Oncology of the European Institute of Oncology in Milan have revealed how to eliminate cancer stem cells, the true reason for cancer’s incurability. Researchers led by Pier Giuseppe Pelicci, Director of the Department of Experimental Oncology of the European Institute of Oncology, and Professor of general pathology at the University of Milan, have discovered how cancer stem cells become immortal.

The same oncogenes that are responsible for triggering the process of tumor formation, also impede stem cells from growing old, and allow them to maintain their
Read More…

How to cure cancer using stem cells

Historic Hurd Hall on Johns Hopkins’ East Baltimore campus was filled to capacity on Jan. 13 with students, faculty and staff waiting to hear five scientists—all in the early part of their careers—describe their novel ideas on how to cure metastatic cancer.

The five were finalists, chosen from among 44 entrants, in a competition on creative thinking named for John Rangos Sr., chairman of the Rangos Family Foundation, who funded the awards. Each scientist had 10 minutes to present his or her idea and answer questions from a panel of faculty judges, who would select the winners based on the
Read More…